Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ICON reported its financial results for the first quarter ended March 31, 2017. Gross business wins in the first quarter were $580 million and cancellations in the quarter were $59 million, resulting in net business wins of $521 million.
read more
ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2012.
read more
Saturday, September 25, 2021
The Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD announced that ICON, a Dublin-based global provider of drug development and commercialisation services to pharmaceutical, biotechnology and medical device industries, has...
read more
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its participation at the International Society for Pharmacoeconomics and Outcomes Research (...
read more
ICON plc has made the following appointments:
Dr. Susan Anton, Director, Epidemiology and Risk Management Practice, ICON Late Phase & Outcomes Research
Dr. Susan Anton comes to ICON with over 25 years of experience leading international ...
read more
Wednesday, February 06, 2019
ICON announced the release of a new drug safety reporting solution based on an innovative cloud-based system, featuring automated and configurable business rules.
read more
Wednesday, November 22, 2017
ICON announced the launch of FIRECREST Pre-Screen, a digital solution that increases the efficiency and quality of initial patient eligibility assessments.
read more
Thursday, October 27, 2016
ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has further improved its feasibility, protocol optimization and patient recruitment ...
read more
Monday, September 19, 2016
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has completed the previously announced acquisition of Clinical Research Management, Inc. (ClinicalRM).
read more
Tuesday, January 28, 2014
a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Dariush Elahi as Director of Metabolic Research. Based in ICON’s Clinical Pharmacology ...
read more
Thursday, November 11, 2021
ICON plc announces that its Accellacare Site Network has expanded in reach and capabilities through new partnerships with six research sites across four countries.
read more
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has signed a three-year agreement with Pfizer Inc.
read more
Baxter announced the FDA clearance of the Spectrum IQ Infusion System with Dose IQ Safety Software.
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has announced that, as part of its planned succession of executive leadership, Mr. Ciaran Murray will ...
read more
ICON announced it is working with Practice Fusion to leverage active patient data in support of health research.
read more